Tomoyuki Nagata

Dr. Tomoyuki Nagata

The Jikei University School of Medicine, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2015 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
TNTomoyuki Nagata
Tomoyuki Nagata
NKNobuyuki Kobayashi
Nobuyuki Kobayashi
JIJumpei Ishii
Jumpei Ishii
SSShunichiro Shinagawa
Shunichiro Shinagawa
RNRitsuko Nakayama
Ritsuko Nakayama
KNKazuhiko Nakayama
Kazuhiko Nakayama
Background/Aims: In the present study, we examined whether DNA methylation of the brain-derived neurotrophic factor (BDNF) promoter is associated with the manifestation and clinical presentation of Alzheimer's disease (AD). Methods: Of 20 patients with AD and 20 age-matched normal controls (NCs), the DNA methylation of the BDNF promoter (measured using peripheral blood samples) was completely analyzed in 12 patients with AD and 6 NCs. The resulting methylation levels were compared statistically. Next, we investigated the correlation between the DNA methylation levels and the clinical presentation of AD. Results: The total methylation ratio (in %) of the 20 CpG sites was significantly higher in the AD patients (5.08 ± 5.52%) than in the NCs (2.09 ± 0.81%; p < 0.05). Of the 20 CpG sites, the methylation level at the CpG4 site was significantly higher in the AD subjects than in the NCs (p < 0.05). Moreover, the methylation level was significantly and negatively correlated with some neuropsychological test subscores (registration, recall, and prehension behavior scores; p < 0.05). Conclusion: These results suggest that the DNA methylation of the BDNF promoter may significantly influence the manifestation of AD and might be associated with its neurocognitive presentation.

25 November 2010 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
TNTomoyuki Nagata
Tomoyuki Nagata
SSShunichiro Shinagawa
Shunichiro Shinagawa
YOYusuke Ochiai
Yusuke Ochiai
RARyo Aoki
Ryo Aoki
HKHiroo Kasahara
Hiroo Kasahara
KNKazuhiko Nakayama
Kazuhiko Nakayama
Background: Some previous research has hypothesized that executive dysfunction in patients with early Alzheimer's disease (AD) occurs as a result of a disconnection between different cerebral areas. The aim of the present study was to evaluate how the hippocampal volume influences executive function as a non-memory cognitive function.Methods: From 157 consecutive patients with AD or amnestic mild cognitive impairment (A-MCI), we recruited 107 subjects who had a global Clinical Dementia Rating (CDR) of 0.5 or 1.0 and whose degree of hippocampal atrophy had been measured using magnetic resonance imaging (MRI); the severity of atrophy was assessed using the voxel-based specific regional analysis for Alzheimer's disease (VSRAD) system. We divided the subjects into three groups: mild atrophy, 0 < Z-score < 1.0 (N = 21); moderate atrophy, 1.0 ≤ Z-score < 2.0 (N = 46); or severe atrophy, 2.0 ≤ Z-score < 4.0 (N = 40) according to the Z-score and compared the Frontal Assessment Battery (FAB) and its subtest scores between each atrophy group.Results: The results demonstrated that age, sex ratio, duration of illness, education years, MMSE score, Behave-AD score, and proportion of atrophy area in total brain (%) were not significantly different among the three groups. Only the go/no-go score among the six subtests was significantly lower for increasing atrophy severity (P < 0.05). Furthermore, hippocampal atrophy significantly influenced the go/no-go score independently of interactions from whether the diagnosis was early AD or A-MCI (P < 0.05).Conclusion: These results support a significant association between hippocampal atrophy and executive dysfunction as a non-memory cognitive impairment in patients with early AD and A-MCI.

13 June 2012 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
TNTomoyuki Nagata
Tomoyuki Nagata
SSShunichiro Shinagawa
Shunichiro Shinagawa
KNKazutaka Nukariya
Kazutaka Nukariya
HYHisashi Yamada
Hisashi Yamada
KNKazuhiko Nakayama
Kazuhiko Nakayama
In the present study, we examined whether brain-derived neurotrophic factor (BDNF) polymorphism (Val66Met) influenced the changeable executive dysfunction of patients with two separate disease stages: amnestic mild cognitive impairment (A-MCI) or mild Alzheimer disease (AD), which are comparatively similar demented conditions. Among 200 outpatients with dementia and MCI, 146 outpatients with mild AD or A-MCI were recruited and divided into two genotypic groups, valine homozygosity (Val/Val) and methionine (Met) carriers, based on the representative BDNF functional polymorphism Val66Met. Next, we compared the Frontal Assessment Battery (FAB) total and subtest scores between the two genotypic groups according to each of two different disease stages: A-MCI (n = 42) and mild AD (n = 104). Among patients with only a mild stage of AD, the FAB total and go/no-go scores were significantly lower (p < 0.05) among the subjects with the Val/Val genotype than among the Met carriers. However, no significant differences in any other demographic variables were observed between the genotypes according to each of different disease stages. A significant interaction between Val66Met and age was not observed for the FAB scores. These results suggested that the BDNF gene may significantly influence executive dysfunction, including inhibition tasks, among patients with mild-stage AD.

7 October 2016 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
TNTomoyuki Nagata
Tomoyuki Nagata
SNShinichiro Nakajima
Shinichiro Nakajima
SSShunichiro Shinagawa
Shunichiro Shinagawa
EPEric Plitman
Eric Plitman
AGAriel Graff‐Guerrero
Ariel Graff‐Guerrero
KNKazuhiko Nakayama
Kazuhiko Nakayama

12 January 2020 in Psychogeriatrics
Verified
Journal Article
Closed access
PDF file
KTKenji Tagai
Kenji Tagai
TNTomoyuki Nagata
Tomoyuki Nagata
SSShunichiro Shinagawa
Shunichiro Shinagawa
MSMasahiro Shigeta
Masahiro Shigeta

20 November 2013 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
TNTomoyuki Nagata
Tomoyuki Nagata
NKNobuyuki Kobayashi
Nobuyuki Kobayashi
SSShunichiro Shinagawa
Shunichiro Shinagawa
HYHisashi Yamada
Hisashi Yamada
KKKazuhiro Kondo
Kazuhiro Kondo
KNKazuhiko Nakayama
Kazuhiko Nakayama